Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The role of hyperthermic intraperitoneal chemotherapy using paclitaxel in platinum-sensitive recurrent epithelial ovarian cancer patients with microscopic residual disease after cytoreduction.
Cascales-Campos PA, Gil J, Feliciangeli E, Gil E, González-Gil A, López V, Ruiz-Pardo J, Nieto A, Parrilla JJ, Parrilla P. Cascales-Campos PA, et al. Ann Surg Oncol. 2015 Mar;22(3):987-93. doi: 10.1245/s10434-014-4049-z. Epub 2014 Sep 12. Ann Surg Oncol. 2015. PMID: 25212832
Risk factors and management of incisional hernia after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal surface malignancies.
Cascales Campos PA, González-Gil A, Gómez-Ruiz AJ, Gil-Gómez E, Alconchel-Gago F, Navarro-Barrios A, Martínez-García J, Alonso-Romero JL, Nieto A, Barceló-Valcarcel F, Gil-Martínez J. Cascales Campos PA, et al. Hernia. 2020 Apr;24(2):257-263. doi: 10.1007/s10029-019-01962-4. Epub 2019 May 8. Hernia. 2020. PMID: 31069579 Clinical Trial.
Peritoneal Surface Disease Severity Score (PSDSS), AGO-score and TIAN model in patients with platinum-sensitive recurrent ovarian cancer treated by cytoreductive surgery plus HIPEC.
Gómez-Ruiz ÁJ, González-Gil A, Gil J, Navarro-Barrios Á, Alconchel F, Gil E, Martínez J, Nieto A, Barceló F, Cascales-Campos PA. Gómez-Ruiz ÁJ, et al. Clin Exp Metastasis. 2019 Oct;36(5):433-439. doi: 10.1007/s10585-019-09982-1. Epub 2019 Jul 3. Clin Exp Metastasis. 2019. PMID: 31270731
Identifying the incidence of respiratory complications following diaphragmatic cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy.
Cascales Campos P, Martinez Insfran LA, Wallace D, Gil J, Gil E, Gonzalez Gil A, Martínez J, Alonso Romero JL, Gonzalez Sanchez R, Parrilla P. Cascales Campos P, et al. Clin Transl Oncol. 2020 Jun;22(6):852-859. doi: 10.1007/s12094-019-02195-8. Epub 2019 Aug 7. Clin Transl Oncol. 2020. PMID: 31392644
Acute renal disease in patients with ovarian peritoneal carcinomatosis treated with cytoreduction and HIPEC: the influence of surgery and the cytostatic agent used.
Gómez-Ruiz ÁJ, González-Gil A, Gil J, Alconchel F, Navarro-Barrios Á, Gil-Gómez E, Martínez J, Nieto A, García-Palenciano C, Cascales-Campos PA. Gómez-Ruiz ÁJ, et al. Langenbecks Arch Surg. 2021 Nov;406(7):2449-2456. doi: 10.1007/s00423-021-02279-6. Epub 2021 Jul 20. Langenbecks Arch Surg. 2021. PMID: 34283300
77 results